Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab
Crossref DOI link: https://doi.org/10.1186/s13550-017-0297-9
Published Online: 2017-05-30
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Patel, Neel http://orcid.org/0000-0002-7412-5493
Able, Sarah
Allen, Danny
Fokas, Emmanouil
Cornelissen, Bart
Gleeson, Fergus V.
Harris, Adrian L.
Vallis, Katherine A.
License valid from 2017-05-30